Hypoxia and the hypoxia-inducible-factor pathway in glioma growth and angiogenesis, Neuro Oncol, vol.7, pp.134-53, 2005. ,
Malignant gliomas: old and new systemic treatment approaches, Radiol Oncol, vol.50, pp.129-167, 2016. ,
IDH1 and IDH2 mutations in tumorigenesis: mechanistic insights and clinical perspectives, Clin Cancer Res, vol.18, pp.5562-71, 2012. ,
What a difference a hydroxyl makes: mutant IDH, (R)-2-hydroxyglutarate, and cancer, Genes Dev, vol.27, pp.836-52, 2013. ,
Cancer-associated IDH1 mutations produce 2-hydroxyglutarate, Nature, vol.462, pp.739-783, 2009. ,
Leukemic IDH1 and IDH2 mutations result in a hypermethylation phenotype, disrupt TET2 function, and impair hematopoietic differentiation, Cancer Cell, vol.18, pp.553-67, 2010. ,
Analytical approaches toward successful human cell metabolome studies by NMR spectroscopy, Anal Chem, vol.81, pp.5023-5055, 2009. ,
Cell culture metabolomics: applications and future directions, Drug Discov Today, vol.15, pp.610-631, 2010. ,
Towards quantitative metabolomics of mammalian cells: development of a metabolite extraction protocol, Anal Biochem, vol.404, pp.155-64, 2010. ,
Optimizing high-throughput metabolomic biomarker screening: a study of quenching solutions to freeze intracellular metabolism in CHO cells, Omics, vol.16, pp.90-97, 2012. ,
Metabolomic profiling with NMR discriminates between biphosphonate and doxorubicin effects on B16 melanoma cells, NMR Biomed, vol.23, pp.1009-1025, 2010. ,
URL : https://hal.archives-ouvertes.fr/hal-00609861
Metabolic impact of anti-angiogenic agents on U87 glioma cells, PLoS One, vol.9, p.99198, 2014. ,
URL : https://hal.archives-ouvertes.fr/hal-02489933
Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays, J Immunol Methods, vol.65, pp.55-63, 1983. ,
NMRPipe: a multidimensional spectral processing system based on UNIX pipes, J Biomol NMR, vol.6, pp.277-93, 1995. ,
Orthogonal projections to latent structures (O-PLS), Journal of Chemometrics, vol.16, pp.119-147, 2002. ,
Understanding the Warburg effect: The metabolic requirements of cell proliferation, Science, vol.324, pp.1029-1062, 2009. ,
The regulation and cellular functions of phosphatidylcholine hydrolysis, Neuroimaging Clin N Am, vol.269, pp.293-310, 1990. ,
Quantification of microheterogeneity in glioblastoma multiforme with ex vivo high-resolution magic-angle spinning (HRMAS) proton magnetic resonance spectroscopy, Neuro Oncol, vol.2, pp.87-95, 2010. ,
A novel cisplatin mediated apoptosis pathway is associated with acid sphingomyelinase and FAS proapoptotic protein activation in ovarian cancer, Apoptosis, vol.20, pp.960-74, 2015. ,
Nuclear magnetic resonance-visible lipids induced by cationic lipophilic chemotherapeutic agents are accompanied by increased lipid droplet formation and damaged mitochondria, Cancer Res, vol.62, pp.1394-400, 2002. ,
Detection of apoptotic cell death by proton nuclear magnetic resonance spectroscopy, Blood, vol.87, pp.1951-1957, 1996. ,
Quantitative analysis of apoptotic cell death using proton nuclear magnetic resonance spectroscopy, Blood, vol.89, pp.3778-86, 1997. ,
Apoptosis is associated with triacylglycerol accumulation in Jurkat T-cells, Br J Cancer, vol.86, pp.963-70, 2002. ,
Assignment of 1H nuclear magnetic resonance visible polyunsaturated fatty acids in BT4C gliomas undergoing ganciclovir-thymidine kinase gene therapy-induced programmed cell death, Cancer Res, vol.63, pp.3195-201, 2003. ,
Taurine: a potential marker of apoptosis in gliomas, Briti J Cancer, vol.100, pp.789-94, 2009. ,
Single-voxel proton brain spectroscopy exam (PROBE/SV) in patients with primary brain tumors, AJR Am J Roentgenol, vol.167, pp.201-210, 1996. ,
Creatine in cell metabolism and its protective action in cerebral ischemia, Neurosci Behav Physiol, vol.45, pp.476-82, 2015. ,
Metabolic reprogramming in mutant IDH1 glioma cells, PLoS One, vol.10, p.118781, 2015. ,
Profiling the effects of isocitrate dehydrogenase 1 and 2 mutations on the cellular metabolome, Proc Natl Acad Sci, vol.108, pp.3270-3275, 2011. ,
Rethinking the Warburg effect with Myc micromanaging glutamine metabolism, Cancer Res, vol.70, pp.859-62, 2010. ,
Metabolic signatures in apoptotic human cancer cell lines, Omics, vol.15, pp.325-360, 2011. ,
Comparative metabolic flux profiling of melanoma cell lines: beyond the Warburg effect, J Biol Chem, vol.286, pp.42626-42660, 2011. ,
Cancer-associated IDH1 mutations produce 2-hydroxyglutarate, Nature, vol.462, pp.739-783, 2009. ,
Beyond aerobic glycolysis: transformed cells can engage in glutamine metabolism that exceeds the requirement for protein and nucleotide synthesis, Proc Natl Acad Sci, vol.104, pp.19345-50, 2007. ,
Evaluation of 13C isotopic tracers for metabolic flux analysis in mammalian cells, J Biotechnol, vol.144, pp.167-74, 2009. ,
The common feature of leukemia-associated IDH1 and IDH2 mutations is a neomorphic enzyme activity converting alpha-ketoglutarate to 2-hydroxyglutarate, Cancer Cell, vol.17, pp.225-259, 2010. ,